Biomedical subjects
K H Kimbel
Publications and source records attributed to K H Kimbel.
Secrecy and product information.
Explore the source record for details and available documents.
Drug prescribing patterns in Europe.
Explore the source record for details and available documents.
[30 years' spontaneous recording systems of German physicians--results and experiences].
Explore the source record for details and available documents.
"Herbal" medicines and rheumatoid arthritis.
Explore the source record for details and available documents.
[The drug scare and its prevention].
Explore the source record for details and available documents.
[Economic prescription of drugs].
Explore the source record for details and available documents.
[Drug safety through drug legislation].
Explore the source record for details and available documents.
[Quality control for drugs].
Explore the source record for details and available documents.
[The physician and drug costs].
Explore the source record for details and available documents.
[Compulsory prescription for bromocarbamide-containing hypnotics].
Explore the source record for details and available documents.
[Combination of cardiac glycosides and norephedrine?].
Explore the source record for details and available documents.
Adverse reactions to drugs.
Explore the source record for details and available documents.
[Toxicological evaluation criteria (secondary action aspects)].
Explore the source record for details and available documents.
[Information on drugs and the risk of drugs. Staged project for the coordination of measures].
Explore the source record for details and available documents.
[Drug safety--achievable goal or utopia?].
The new German Drug Law, recently passed by the Bundstag (House of Representatives) endeavors to assure safety in drug distribution and use, especially to guarantee the harmlessness of drugs according to the regulations provided by the law. The following contribution tries to analyze how far we have come up to now as to a safe use of drugs, which improvements are possible, what they will cost, and finally who of us must contribute towards a rational compromise between therapeutic success and unavoidable risk.
[Information on drugs and drug hazards--a task of professional policy].
Explore the source record for details and available documents.